Gemcitabine Injection

Generic name: Pronounced as (jem sit' a been)
Brand names
  • Gemzar®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 08/15/2019

Gemcitabine is used in combination with carboplatin to treat ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed) that returned at least 6 months after finishing a previous treatment. It also used in combination with paclitaxel (Abraxane, Taxol) to treat breast cancer that has not improved or that has worsened after treatment with other medications. Gemcitabine is used in combination with cisplatin to treat a type of lung cancer (non-small cell lung cancer; NSCLC) that has spread to other parts of the body and cannot be treated with surgery. Gemcitabine is also used to treat pancreatic cancer that has spread to other parts of the body and has not improved or worsened after treatment with another medication. Gemcitabine is in a class of medications called antimetabolites. It works by slowing or stopping the growth of cancer cells in your body.

Gemcitabine comes as a powder to be mixed with liquid to be injected over 30 minutes intravenously (into a vein) by a doctor or nurse in a medical facility. When gemcitabine is used to treat ovarian or breast cancer, it is usually given on certain days every 3 weeks. When gemcitabine is used to treat lung cancer, it is usually given on certain days every 3 or 4 weeks. When gemcitabine is used to treat pancreatic cancer, it may be injected once every week. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer or condition you have. Your doctor may need to stop or delay your treatment if you experience certain side effects.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

Gemcitabine is also sometimes used to treat bladder cancer and cancer of the biliary tract (cancer in the organs and ducts that make and store bile, the liquid made by the liver). Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving gemcitabine,

  • tell your doctor and pharmacist if you are allergic to gemcitabine, any other medications, or any of the ingredients in gemcitabine. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take.

  • tell your doctor if you drink or have ever drunk large amounts of alcohol or if you have or ever had liver disease, including hepatitis, or kidney disease.

  • tell your doctor if you have previously received or are currently receiving radiation therapy.

  • tell your doctor if you are pregnant, plan to become pregnant, or if you plan to father a child. If you are female, you will need to take a pregnancy test before starting treatment and use effective birth control to prevent a pregnancy during your treatment and for at least 6 months after your final dose. If you are male, you and your female partner should use effective birth control while you are receiving gemcitabine and for 3 months after the final dose. Talk to your doctor about using birth control to prevent pregnancy during your treatment with gemcitabine. If you or your partner become pregnant while receiving gemcitabine, call your doctor. Gemcitabine may harm the fetus.

  • tell your doctor if you are breastfeeding. You should not breastfeed while you are receiving gemcitabine injection and for 1 week after your final dose.

  • you should know that this medication may decrease fertility in men. Talk to your doctor about the risks of receiving gemcitabine.

Unless your doctor tells you otherwise, continue your normal diet.

  • Gemcitabine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • diarrhea

    • constipation

    • loss of appetite

    • sores in the mouth and throat

    • hair loss

    • headache

    • sore or painful muscles

    • pain, burning, or tingling in the hands or feet

    • swelling, pain, redness, or burning at the injection site

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately :

    • rash, itching, hives, throat or tongue swelling, shortness of breath, difficulty breathing, vomiting, lightheadedness, or fainting

    • unusual bleeding or bruising, red or black tarry stools, or coughing up or vomiting blood or material that looks like coffee grounds

    • changes in volume of urine

    • fever, sore throat, ongoing cough and congestion, or other signs of infection

    • unusual tiredness or weakness, shortness of breath, or wheezing

    • yellowing of the skin or eyes, dark urine, loss of appetite, fatigue, or pain or discomfort in right upper stomach area

    • swelling of the feet, ankles, or lower legs; stomach pain; watery stools; or tiredness

    • fast, irregular, or pounding heartbeat

    • headache, seizures, tiredness, confusion, or vision changes

  • Gemcitabine may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • severe rash

  • pain, burning, or tingling in the hands or feet

  • unusual bleeding or bruising

  • red or black, tarry stools

  • pink, red, or dark brown urine

  • coughing up or vomiting blood or material that looks like coffee grounds

  • fever, sore throat, ongoing cough and congestion, or other signs of infection

  • extreme tiredness

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests before and during your treatment to check your body's response to gemcitabine.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Gemcitabine is combined with Leflunomide.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Gemcitabine.
Cilostazol Cilostazol Gemcitabine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Clopidogrel Clopidogrel The risk or severity of bleeding can be increased when Clopidogrel is combined with Gemcitabine.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Gemcitabine can be increased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Fenofibrate Fenofibrate Gemcitabine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine Gemcitabine may decrease the excretion rate of Guanfacine which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide Gemcitabine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Gemcitabine is combined with Mycophenolic acid.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Paregoric Paregoric The serum concentration of Gemcitabine can be increased when it is combined with Morphine.
Potassium Potassium Potassium may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Gemcitabine is combined with Prednisone.
Ranitidine Ranitidine Gemcitabine may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine The serum concentration of Gemcitabine can be increased when it is combined with Reserpine.
Rizatriptan Rizatriptan Gemcitabine may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Gemcitabine may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Gemcitabine.
Triamcinolone Triamcinolone The risk or severity of adverse effects can be increased when Gemcitabine is combined with Triamcinolone.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection The serum concentration of Gemcitabine can be increased when it is combined with Fluconazole.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Gemcitabine.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gemcitabine.
Levofloxacin Injection Levofloxacin Injection Gemcitabine may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection Gemcitabine may decrease the excretion rate of Meperidine which could result in a higher serum level.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection Gemcitabine may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
Morphine Injection Morphine Injection The serum concentration of Gemcitabine can be increased when it is combined with Morphine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Gemcitabine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Zidovudine.
Altretamine Altretamine Amphetamine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cyclosporine Cyclosporine Gemcitabine may increase the immunosuppressive activities of Cyclosporine.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Gemcitabine.
Torsemide Torsemide Torasemide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Hydroxychloroquine.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Gemcitabine is combined with Temozolomide.
Zaleplon Zaleplon Gemcitabine may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Gemcitabine.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Gemcitabine is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Gemcitabine.
Trimipramine Trimipramine The serum concentration of Trimipramine can be increased when it is combined with Gemcitabine.
Etanercept Injection Etanercept Injection The risk or severity of adverse effects can be increased when Etanercept is combined with Gemcitabine.
Perindopril Perindopril Gemcitabine may decrease the excretion rate of Perindopril which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Sirolimus Sirolimus The risk or severity of adverse effects can be increased when Gemcitabine is combined with Sirolimus.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Gemcitabine is combined with Epirubicin.
Eplerenone Eplerenone Eplerenone may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Zonisamide Zonisamide The serum concentration of Zonisamide can be increased when it is combined with Gemcitabine.
Adalimumab Injection Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemcitabine.
Atomoxetine Atomoxetine Atomoxetine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Glatiramer.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Almotriptan Almotriptan Gemcitabine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Vardenafil Vardenafil The serum concentration of Gemcitabine can be increased when it is combined with Vardenafil.
Emtricitabine Emtricitabine Gemcitabine may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Gemcitabine may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod Tegaserod The serum concentration of Gemcitabine can be increased when it is combined with Tegaserod.
Tadalafil Tadalafil Gemcitabine may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gemcitabine.
Infliximab Injection Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Gemcitabine.
Duloxetine Duloxetine Gemcitabine may decrease the excretion rate of Duloxetine which could result in a higher serum level.
Tinidazole Tinidazole Gemcitabine may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Cefditoren Cefditoren Gemcitabine may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Natalizumab.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Eszopiclone Eszopiclone Eszopiclone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Ganciclovir Ganciclovir Gemcitabine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Gemcitabine.
Ribavirin Ribavirin Gemcitabine may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Valganciclovir Valganciclovir Gemcitabine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Adefovir Adefovir Adefovir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gemcitabine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gemcitabine.
Ramelteon Ramelteon Gemcitabine may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Fentanyl Fentanyl Gemcitabine may decrease the excretion rate of Fentanyl which could result in a higher serum level.
Pregabalin Pregabalin Pregabalin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Tipranavir Tipranavir The serum concentration of Gemcitabine can be decreased when it is combined with Tipranavir.
Ranolazine Ranolazine The serum concentration of Gemcitabine can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Abatacept.
Rasagiline Rasagiline Gemcitabine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Imatinib Imatinib The risk or severity of adverse effects can be increased when Gemcitabine is combined with Imatinib.
Sitagliptin Sitagliptin The serum concentration of Sitagliptin can be increased when it is combined with Gemcitabine.
Varenicline Varenicline Gemcitabine may decrease the excretion rate of Varenicline which could result in a higher serum level.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Gemcitabine.
Albuterol Albuterol Gemcitabine may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone The serum concentration of Paliperidone can be increased when it is combined with Gemcitabine.
Bortezomib Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Gemcitabine.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Clofarabine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Gemcitabine.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Gemcitabine.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Gemcitabine.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Gemcitabine.
Lubiprostone Lubiprostone Gemcitabine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Oxaliplatin.
Posaconazole Posaconazole The serum concentration of Gemcitabine can be increased when it is combined with Posaconazole.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Gemcitabine.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Pemetrexed.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Gemcitabine is combined with Vorinostat.
Sorafenib Sorafenib The serum concentration of Gemcitabine can be increased when it is combined with Sorafenib.
Sunitinib Sunitinib The risk or severity of adverse effects can be increased when Gemcitabine is combined with Sunitinib.
Lapatinib Lapatinib The serum concentration of Gemcitabine can be increased when it is combined with Lapatinib.
Levocetirizine Levocetirizine Gemcitabine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Gemcitabine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dasatinib.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Azacitidine.
Temsirolimus Temsirolimus The serum concentration of Temsirolimus can be increased when it is combined with Gemcitabine.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Gemcitabine is combined with Lenalidomide.
Nilotinib Nilotinib The serum concentration of Nilotinib can be increased when it is combined with Gemcitabine.
Toremifene Toremifene The serum concentration of Gemcitabine can be increased when it is combined with Toremifene.
Bexarotene Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Gemcitabine.
Budesonide Budesonide The risk or severity of adverse effects can be increased when Gemcitabine is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Chloramphenicol.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Decitabine.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Doripenem Injection Doripenem Injection Gemcitabine may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The serum concentration of Gemcitabine can be decreased when it is combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine Gemcitabine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Gemcitabine is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Bendamustine.
Certolizumab Injection Certolizumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Irinotecan.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Estramustine.
Methylnaltrexone Injection Methylnaltrexone Injection Gemcitabine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Gemcitabine.
Silodosin Silodosin The serum concentration of Gemcitabine can be increased when it is combined with Silodosin.
Midazolam Midazolam Gemcitabine may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Gemcitabine.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Gemcitabine.
Milnacipran Milnacipran Gemcitabine may decrease the excretion rate of Milnacipran which could result in a higher serum level.
Plerixafor Injection Plerixafor Injection Gemcitabine may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Gemcitabine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Prasugrel Prasugrel Gemcitabine may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Everolimus Everolimus The risk or severity of adverse effects can be increased when Gemcitabine is combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The serum concentration of Gemcitabine can be increased when it is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Saxagliptin Saxagliptin Gemcitabine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Gemcitabine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The serum concentration of Romidepsin can be increased when it is combined with Gemcitabine.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Gemcitabine is combined with Topotecan.
Golimumab Injection Golimumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Golimumab.
Pazopanib Pazopanib The risk or severity of adverse effects can be increased when Gemcitabine is combined with Pazopanib.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Gemcitabine.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Gemcitabine.
Tocilizumab Injection Tocilizumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Tocilizumab.
Dalfampridine Dalfampridine Gemcitabine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Fingolimod Fingolimod Gemcitabine may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Cabazitaxel.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Ipilimumab Injection Ipilimumab Injection Gemcitabine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gemcitabine.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Gemcitabine.
Terbutaline Injection Terbutaline Injection Gemcitabine may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Belimumab.
Busulfan Injection Busulfan Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Busulfan.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Gemcitabine.
Linagliptin Linagliptin The serum concentration of Gemcitabine can be increased when it is combined with Linagliptin.
Telaprevir Telaprevir The serum concentration of Gemcitabine can be increased when it is combined with Glecaprevir.
Cyclophosphamide Injection Cyclophosphamide Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Cyclophosphamide.
Rivaroxaban Rivaroxaban The serum concentration of Rivaroxaban can be increased when it is combined with Gemcitabine.
Ticagrelor Ticagrelor The serum concentration of Gemcitabine can be increased when it is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ruxolitinib.
Vandetanib Vandetanib The serum concentration of Gemcitabine can be increased when it is combined with Vandetanib.
Clobazam Clobazam The serum concentration of Gemcitabine can be increased when it is combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Gemcitabine can be increased when it is combined with Vemurafenib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Belatacept.
Ivacaftor Ivacaftor The serum concentration of Gemcitabine can be increased when it is combined with Ivacaftor.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Gemcitabine.
Deferiprone Deferiprone Gemcitabine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The serum concentration of Axitinib can be increased when it is combined with Gemcitabine.
Crizotinib Crizotinib The serum concentration of Gemcitabine can be increased when it is combined with Crizotinib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Melphalan.
Cabergoline Cabergoline The serum concentration of Cabergoline can be increased when it is combined with Gemcitabine.
Naloxone Injection Naloxone Injection Gemcitabine may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan The serum concentration of Gemcitabine can be increased when it is combined with Ambrisentan.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection Gemcitabine may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
Carfilzomib Injection Carfilzomib Injection The serum concentration of Carfilzomib can be increased when it is combined with Gemcitabine.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Gemcitabine.
Enzalutamide Enzalutamide The serum concentration of Enzalutamide can be increased when it is combined with Gemcitabine.
Mirabegron Mirabegron The serum concentration of Mirabegron can be increased when it is combined with Gemcitabine.
Regorafenib Regorafenib The serum concentration of Gemcitabine can be increased when it is combined with Regorafenib.
Bosutinib Bosutinib The risk or severity of adverse effects can be increased when Gemcitabine is combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Gemcitabine is combined with Teriflunomide.
Teduglutide Injection Teduglutide Injection Gemcitabine may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Gemcitabine.
Tofacitinib Tofacitinib Gemcitabine may increase the immunosuppressive activities of Tofacitinib.
Alogliptin Alogliptin Gemcitabine may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dimethyl fumarate.
Ponatinib Ponatinib The serum concentration of Ponatinib can be increased when it is combined with Gemcitabine.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Gemcitabine is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Trastuzumab emtansine.
Apixaban Apixaban The serum concentration of Gemcitabine can be increased when it is combined with Apixaban.
Canagliflozin Canagliflozin The serum concentration of Canagliflozin can be increased when it is combined with Gemcitabine.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The serum concentration of Dabrafenib can be increased when it is combined with Gemcitabine.
Trametinib Trametinib Gemcitabine may decrease the excretion rate of Trametinib which could result in a higher serum level.
Dolutegravir Dolutegravir The serum concentration of Gemcitabine can be increased when it is combined with Dolutegravir.
Afatinib Afatinib The serum concentration of Gemcitabine can be increased when it is combined with Afatinib.
Levomilnacipran Levomilnacipran Gemcitabine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Vortioxetine Vortioxetine Gemcitabine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ibrutinib.
Lomitapide Lomitapide The serum concentration of Gemcitabine can be increased when it is combined with Lomitapide.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Obinutuzumab.
Simeprevir Simeprevir The serum concentration of Gemcitabine can be increased when it is combined with Simeprevir.
Sofosbuvir Sofosbuvir The serum concentration of Sofosbuvir can be increased when it is combined with Gemcitabine.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast The risk or severity of adverse effects can be increased when Gemcitabine is combined with Apremilast.
Droxidopa Droxidopa Gemcitabine may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The serum concentration of Ceritinib can be increased when it is combined with Gemcitabine.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Belinostat.
Idelalisib Idelalisib The risk or severity of adverse effects can be increased when Gemcitabine is combined with Idelalisib.
Testosterone Injection Testosterone Injection Gemcitabine may decrease the excretion rate of Testosterone which could result in a higher serum level.
Vorapaxar Vorapaxar The serum concentration of Gemcitabine can be increased when it is combined with Vorapaxar.
Suvorexant Suvorexant The serum concentration of Gemcitabine can be increased when it is combined with Suvorexant.
Edoxaban Edoxaban The serum concentration of Edoxaban can be increased when it is combined with Gemcitabine.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Peginterferon beta-1a.
Olaparib Olaparib The risk or severity of adverse effects can be increased when Gemcitabine is combined with Olaparib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Blinatumomab.
Methamphetamine Methamphetamine Gemcitabine may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon Gemcitabine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Gemcitabine is combined with Pirfenidone.
Nintedanib Nintedanib The serum concentration of Gemcitabine can be increased when it is combined with Nintedanib.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Secukinumab.
Palbociclib Palbociclib The serum concentration of Palbociclib can be increased when it is combined with Gemcitabine.
Lenvatinib Lenvatinib The serum concentration of Gemcitabine can be increased when it is combined with Lenvatinib.
Panobinostat Panobinostat The risk or severity of adverse effects can be increased when Gemcitabine is combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection Gemcitabine may decrease the excretion rate of Haloperidol which could result in a higher serum level.
Amiloride Amiloride Amiloride may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Gemcitabine can be increased when it is combined with Isavuconazonium.
Macitentan Macitentan Gemcitabine may decrease the excretion rate of Macitentan which could result in a higher serum level.
Flibanserin Flibanserin The serum concentration of Gemcitabine can be increased when it is combined with Flibanserin.
Rolapitant Rolapitant The serum concentration of Gemcitabine can be increased when it is combined with Rolapitant.
Prednisolone Prednisolone The risk or severity of adverse effects can be increased when Gemcitabine is combined with Prednisolone.
Daclatasvir Daclatasvir The serum concentration of Gemcitabine can be increased when it is combined with Daclatasvir.
Penicillin G Procaine Injection Penicillin G Procaine Injection Gemcitabine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Cobimetinib Cobimetinib The serum concentration of Cobimetinib can be increased when it is combined with Gemcitabine.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Trabectedin.
Osimertinib Osimertinib The serum concentration of Osimertinib can be increased when it is combined with Gemcitabine.
Ixazomib Ixazomib Gemcitabine may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Gemcitabine may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dexamethasone.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Gemcitabine.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection Gemcitabine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Venetoclax Venetoclax The serum concentration of Gemcitabine can be increased when it is combined with Venetoclax.
Cobicistat Cobicistat The serum concentration of Gemcitabine can be increased when it is combined with Cobicistat.
Selexipag Selexipag The serum concentration of Gemcitabine can be increased when it is combined with Selexipag.
Furosemide Injection Furosemide Injection Gemcitabine may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The serum concentration of Gemcitabine can be increased when it is combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Gemcitabine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Brodalumab.
Doxepin (Insomnia) Doxepin (Insomnia) Gemcitabine may decrease the excretion rate of Doxepin which could result in a higher serum level.
Deutetrabenazine Deutetrabenazine Gemcitabine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Gemcitabine may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The risk or severity of adverse effects can be increased when Gemcitabine is combined with Deflazacort.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Gemcitabine.
Naldemedine Naldemedine Gemcitabine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Sarilumab.
Neratinib Neratinib The serum concentration of Gemcitabine can be increased when it is combined with Neratinib.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Guselkumab.
Enasidenib Enasidenib The serum concentration of Gemcitabine can be increased when it is combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Gemcitabine.
Benznidazole Benznidazole Gemcitabine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The serum concentration of Copanlisib can be increased when it is combined with Gemcitabine.
Delafloxacin Delafloxacin Gemcitabine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Abemaciclib Abemaciclib The serum concentration of Abemaciclib can be increased when it is combined with Gemcitabine.
Betrixaban Betrixaban The serum concentration of Gemcitabine can be increased when it is combined with Betrixaban.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Gemcitabine.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Apalutamide Apalutamide The serum concentration of Apalutamide can be decreased when it is combined with Gemcitabine.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Penicillamine.
Avatrombopag Avatrombopag The serum concentration of Gemcitabine can be increased when it is combined with Avatrombopag.
Baricitinib Baricitinib The risk or severity of adverse effects can be increased when Gemcitabine is combined with Baricitinib.
Lofexidine Lofexidine Gemcitabine may decrease the excretion rate of Lofexidine which could result in a higher serum level.
Plazomicin Injection Plazomicin Injection Gemcitabine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The serum concentration of Gemcitabine can be increased when it is combined with Eliglustat.
Binimetinib Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Gemcitabine.
Ivosidenib Ivosidenib The serum concentration of Gemcitabine can be increased when it is combined with Ivosidenib.
Lusutrombopag Lusutrombopag The serum concentration of Gemcitabine can be increased when it is combined with Lusutrombopag.
Elagolix Elagolix The serum concentration of Gemcitabine can be increased when it is combined with Elagolix.
Dacomitinib Dacomitinib The serum concentration of Gemcitabine can be increased when it is combined with Dacomitinib.
Duvelisib Duvelisib The serum concentration of Gemcitabine can be increased when it is combined with Duvelisib.
Omadacycline Omadacycline The serum concentration of Gemcitabine can be increased when it is combined with Omadacycline.
Sarecycline Sarecycline The serum concentration of Gemcitabine can be increased when it is combined with Sarecycline.
Stiripentol Stiripentol Gemcitabine may decrease the excretion rate of Stiripentol which could result in a higher serum level.
Talazoparib Talazoparib The serum concentration of Talazoparib can be increased when it is combined with Gemcitabine.
Gilteritinib Gilteritinib The serum concentration of Gemcitabine can be increased when it is combined with Gilteritinib.
Glasdegib Glasdegib The serum concentration of Gemcitabine can be increased when it is combined with Glasdegib.
Larotrectinib Larotrectinib The serum concentration of Gemcitabine can be increased when it is combined with Larotrectinib.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gemcitabine.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Paclitaxel.
Rifamycin Rifamycin The serum concentration of Gemcitabine can be increased when it is combined with Rifamycin.
Prucalopride Prucalopride Gemcitabine may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Emapalumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Gemcitabine is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Gemcitabine.
Erdafitinib Erdafitinib The serum concentration of Gemcitabine can be increased when it is combined with Erdafitinib.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Risankizumab.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Gemcitabine.
Solriamfetol Solriamfetol Gemcitabine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Darolutamide Darolutamide The serum concentration of Gemcitabine can be increased when it is combined with Darolutamide.
Entrectinib Entrectinib The serum concentration of Gemcitabine can be increased when it is combined with Entrectinib.
Istradefylline Istradefylline The serum concentration of Gemcitabine can be increased when it is combined with Istradefylline.
Pitolisant Pitolisant The serum concentration of Pitolisant can be increased when it is combined with Gemcitabine.
Fedratinib Fedratinib The serum concentration of Gemcitabine can be increased when it is combined with Fedratinib.
Lefamulin Lefamulin The serum concentration of Gemcitabine can be increased when it is combined with Lefamulin.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Gemcitabine can be increased when it is combined with Enfortumab vedotin.
Lasmiditan Lasmiditan The serum concentration of Gemcitabine can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Gemcitabine can be increased when it is combined with Ubrogepant.
Tazemetostat Tazemetostat The serum concentration of Gemcitabine can be increased when it is combined with Tazemetostat.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ozanimod.
Selumetinib Selumetinib The serum concentration of Gemcitabine can be increased when it is combined with Selumetinib.
Rimegepant Rimegepant The serum concentration of Gemcitabine can be increased when it is combined with Rimegepant.
Tucatinib Tucatinib Tucatinib may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Remdesivir Injection Remdesivir Injection The serum concentration of Gemcitabine can be increased when it is combined with Remdesivir.
Ripretinib Ripretinib The serum concentration of Gemcitabine can be increased when it is combined with Ripretinib.
Capmatinib Capmatinib The serum concentration of Gemcitabine can be increased when it is combined with Capmatinib.
Lemborexant Lemborexant The serum concentration of Gemcitabine can be increased when it is combined with Lemborexant.
Fostemsavir Fostemsavir The serum concentration of Gemcitabine can be increased when it is combined with Fostemsavir.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The serum concentration of Gemcitabine can be increased when it is combined with Belantamab mafodotin.
Pralsetinib Pralsetinib The serum concentration of Gemcitabine can be increased when it is combined with Pralsetinib.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine Gemcitabine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Gemcitabine.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Trazodone Trazodone The serum concentration of Gemcitabine can be decreased when it is combined with Trazodone.
Isotretinoin Isotretinoin Gemcitabine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Gemcitabine is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Gemcitabine.
Metaxalone Metaxalone Gemcitabine may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Methotrexate.
Chlorpromazine Chlorpromazine Gemcitabine may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
Diazepam Diazepam Gemcitabine may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam Oxazepam Gemcitabine may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Gemcitabine may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Gemcitabine may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam Lorazepam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Gemcitabine.
Amantadine Amantadine Gemcitabine may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Codeine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Phenelzine Phenelzine Gemcitabine may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Procarbazine.
Tetracycline Tetracycline Gemcitabine may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Gemcitabine.
Bleomycin Bleomycin The risk or severity of pulmonary toxicity can be increased when Gemcitabine is combined with Bleomycin.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Methadone Methadone Methadone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Benztropine Benztropine Benzatropine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Maprotiline Maprotiline Gemcitabine may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Azathioprine.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Sulfasalazine.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Lomustine.
Doxorubicin Doxorubicin The risk or severity of adverse effects can be increased when Gemcitabine is combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dactinomycin.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Carbamazepine Carbamazepine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Carbamazepine.
Methyldopa Methyldopa Gemcitabine may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Hydralazine Hydralazine Gemcitabine may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine Gemcitabine may decrease the excretion rate of Cimetidine which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Warfarin Warfarin The therapeutic efficacy of Warfarin can be increased when used in combination with Gemcitabine.
Clonazepam Clonazepam Gemcitabine may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The serum concentration of Gemcitabine can be increased when it is combined with Loperamide.
Promethazine Promethazine Gemcitabine may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Gemcitabine is combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Gemcitabine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin Gemcitabine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine Loxapine The serum concentration of Gemcitabine can be increased when it is combined with Loxapine.
Chloroquine Chloroquine Gemcitabine may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Quinine Quinine The serum concentration of Gemcitabine can be increased when it is combined with Quinine.
Triamterene Triamterene Triamterene may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Gemcitabine.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Gemcitabine may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital Secobarbital may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Desipramine Desipramine Gemcitabine may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline Amitriptyline Amitriptyline may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Imipramine Imipramine The serum concentration of Imipramine can be increased when it is combined with Gemcitabine.
Probenecid Probenecid Gemcitabine may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine The serum concentration of Quinidine can be increased when it is combined with Gemcitabine.
Procainamide Procainamide Gemcitabine may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid Gemcitabine may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Rifampin Rifampin The serum concentration of Gemcitabine can be decreased when it is combined with Rifampicin.
Disopyramide Disopyramide Disopyramide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Tamoxifen Tamoxifen The serum concentration of Gemcitabine can be increased when it is combined with Tamoxifen.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Gemcitabine.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Levothyroxine Levothyroxine The serum concentration of Gemcitabine can be decreased when it is combined with Levothyroxine.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Methimazole Methimazole The risk or severity of adverse effects can be increased when Gemcitabine is combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Gemcitabine is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide Gemcitabine may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
Tolbutamide Tolbutamide Gemcitabine may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
Tolazamide Tolazamide Gemcitabine may decrease the excretion rate of Tolazamide which could result in a higher serum level.
Baclofen Baclofen Baclofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Gemcitabine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Nortriptyline Nortriptyline The serum concentration of Nortriptyline can be increased when it is combined with Gemcitabine.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Mercaptopurine.
Phytonadione Phytonadione Gemcitabine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Nadolol Nadolol Gemcitabine may decrease the excretion rate of Nadolol which could result in a higher serum level.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Gemcitabine.
Clomiphene Clomiphene The serum concentration of Gemcitabine can be increased when it is combined with Clomifene.
Flavoxate Flavoxate Gemcitabine may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection The serum concentration of Fluorouracil can be increased when it is combined with Gemcitabine.
Colchicine Colchicine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Colchicine.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dacarbazine.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Gemcitabine.
Ketoconazole Ketoconazole The serum concentration of Gemcitabine can be increased when it is combined with Ketoconazole.
Pyrantel Pyrantel Gemcitabine may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Thiotepa.
Vincristine Injection Vincristine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Vincristine.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Gemcitabine.
Vinblastine Vinblastine The risk or severity of adverse effects can be increased when Gemcitabine is combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Metoprolol Metoprolol Metoprolol may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Gemcitabine.
Alprazolam Alprazolam Alprazolam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Temazepam Temazepam Temazepam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Triazolam Triazolam Gemcitabine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Gemcitabine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Gemcitabine may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Nifedipine Nifedipine Gemcitabine may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Timolol Timolol Timolol may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Verapamil Verapamil The serum concentration of Verapamil can be increased when it is combined with Gemcitabine.
Pindolol Pindolol Gemcitabine may decrease the excretion rate of Pindolol which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Cisplatin.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Bumetanide Bumetanide Gemcitabine may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Gemcitabine.
Etoposide Etoposide The risk or severity of adverse effects can be increased when Gemcitabine is combined with Etoposide.
Glipizide Glipizide Gemcitabine may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide Gemcitabine may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin Amoxicillin Gemcitabine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Gemcitabine may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Gemcitabine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Labetalol Labetalol Gemcitabine may decrease the excretion rate of Labetalol which could result in a higher serum level.
Auranofin Auranofin Gemcitabine may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Gemfibrozil Gemfibrozil Gemcitabine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Amiodarone Amiodarone The serum concentration of Gemcitabine can be increased when it is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Buspirone Buspirone Gemcitabine may decrease the excretion rate of Buspirone which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin Gemcitabine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Gemcitabine.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Gemcitabine is combined with Clozapine.
Estazolam Estazolam Gemcitabine may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Gemcitabine is combined with Idarubicin.
Didanosine Didanosine Gemcitabine may decrease the excretion rate of Didanosine which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Pentostatin.
Clarithromycin Clarithromycin The serum concentration of Gemcitabine can be increased when it is combined with Clarithromycin.
Etodolac Etodolac Etodolac may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Fosinopril Fosinopril Gemcitabine may decrease the excretion rate of Fosinopril which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Pravastatin Pravastatin The serum concentration of Gemcitabine can be increased when it is combined with Pravastatin.
Simvastatin Simvastatin The serum concentration of Gemcitabine can be increased when it is combined with Simvastatin.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemcitabine.
Teniposide Injection Teniposide Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Teniposide.
Itraconazole Itraconazole The serum concentration of Gemcitabine can be increased when it is combined with Itraconazole.
Lisinopril Lisinopril Gemcitabine may decrease the excretion rate of Lisinopril which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Bisoprolol Bisoprolol The serum concentration of Bisoprolol can be increased when it is combined with Gemcitabine.
Isradipine Isradipine Isradipine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Venlafaxine Venlafaxine Venlafaxine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Nefazodone Nefazodone Gemcitabine may decrease the excretion rate of Nefazodone which could result in a higher serum level.
Lamotrigine Lamotrigine Gemcitabine may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Tramadol Tramadol Tramadol may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Vinorelbine Injection Vinorelbine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Gemcitabine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Carboplatin.
Ifosfamide Injection Ifosfamide Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ifosfamide.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Gemcitabine.
Bupropion Bupropion Gemcitabine may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine Ticlopidine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Saquinavir Saquinavir The serum concentration of Gemcitabine can be increased when it is combined with Saquinavir.
Metformin Metformin Metformin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Gemcitabine.
Nisoldipine Nisoldipine Nisoldipine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Lamivudine Lamivudine Gemcitabine may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Acarbose Acarbose Acarbose may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Ritonavir Ritonavir The serum concentration of Gemcitabine can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Docetaxel.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Meropenem Injection Meropenem Injection Gemcitabine may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine Gemcitabine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Fosfomycin Fosfomycin Gemcitabine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Topiramate Topiramate Topiramate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Fexofenadine Fexofenadine The serum concentration of Gemcitabine can be increased when it is combined with Fexofenadine.
Carvedilol Carvedilol The serum concentration of Gemcitabine can be increased when it is combined with Carvedilol.
Nilutamide Nilutamide Gemcitabine may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide Gemcitabine may decrease the excretion rate of Flutamide which could result in a higher serum level.
Propafenone Propafenone The serum concentration of Gemcitabine can be increased when it is combined with Propafenone.
Tamsulosin Tamsulosin Gemcitabine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Quetiapine Quetiapine Gemcitabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cetirizine Cetirizine Cetirizine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Capecitabine Capecitabine The serum concentration of Capecitabine can be increased when it is combined with Gemcitabine.
Abacavir Abacavir Gemcitabine may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The serum concentration of Gemcitabine can be increased when it is combined with Sildenafil.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Gemcitabine.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Tolterodine Tolterodine Gemcitabine may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Gemcitabine is combined with Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Nateglinide Nateglinide Gemcitabine may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Rabeprazole Rabeprazole Gemcitabine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists

Still Confused? Ask the pharmacist a question here!